MCM
MBIO icon

MAI Capital Management’s Mustang Bio MBIO Stock Holding History

MAI Capital Management’s Portfolio MBIO Stock Details MBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3 Hold
3
– – ﹤0.01% 5002
2025
Q4 		$3 Buy
+3
New +$4 ﹤0.01% 4342
2023
Q2 		– Sell
-27
Closed -$7.33K – 1104
2023
Q1 		$7.33K Hold
27
– – ﹤0.01% 1029
2022
Q4 		$7.9K Buy
+27
New +$9.22K ﹤0.01% 998

Other funds holding MBIO

KAS
Kestra Advisory Services Austin, Texas $26.4B AUM 21.05% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CG
CFO4Life Group Coppell, Texas $656M AUM 17.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

MAI Capital Management's MBIO Position: Q1 2026 in Review

MAI Capital Management held its Mustang Bio (MBIO) position steady in Q1 2026 at 3 shares worth $3. The position accounts for ﹤0.01% of the portfolio, ranked #5002.

MAI Capital Management first reported a position in MBIO in Q4 2022 and has held it in 4 quarters since. The position peaked at $7.9K in Q4 2022. 22 funds tracked by Wall St. Rank hold MBIO as of Q1 2026.

  • MAI Capital Management held 3 shares of Mustang Bio worth $3 as of Q1 2026.
  • MAI Capital Management left its Mustang Bio share count unchanged in Q1 2026.
  • Mustang Bio made up ﹤0.01% of MAI Capital Management's portfolio in Q1 2026, its #5002 holding.
  • MAI Capital Management first reported a position in Mustang Bio in Q4 2022 and has held it in 4 quarters since.
  • MAI Capital Management's Mustang Bio position peaked at $7.9K in Q4 2022.
  • 22 funds tracked by Wall St. Rank held Mustang Bio as of Q1 2026.

Based on MAI Capital Management's 13F filing for Q1 2026, filed 15 May 2026.